Skip to content
Home/Companies/MedTech/Acandis
Acandis

Acandis

MedTech·France·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Acandis?

Acandis is a French MedTech company, currently owned by Lauxera Capital Partners since 2024.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Lauxera Capital Partners
Investor
Lauxera Capital Partners
Lauxera Growth II · 2025 · Growth

Key facts

HQFrance
SectorMedTech
Websiteacandis.com

More from Lauxera Growth II

Other portfolio companies in the same fund.

Bridge to Life
Active
MedTechUS· 2026
GenePlanet
Active
BiotechSlovenia· 2026
Antaros Medical
Antaros Medical
Active
BiotechSweden· 2025

More Lauxera Capital Partners portfolio companies

From the same investor, across funds.

Natural Cycles
Natural Cycles
Active
HealthTechSweden· 2024
Ospi
Ospi
Active
HealthTechFrance· 2024
BioLamina
BioLamina
Active
BiotechSweden· 2023
Caresyntax
Active
HealthTechGermany· 2023
Matrix One
Matrix One
Active
HealthTechGermany· 2023
Reapplix
Reapplix
Active
MedTechDenmark· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Acandis?

Acandis is currently owned by Lauxera Capital Partners, through Lauxera Growth II, since 2024.

When did Lauxera Capital Partners acquire Acandis?

Lauxera Capital Partners acquired Acandis in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue